RecruitingNCT06430554
Rare condition
Severe acute respiratory syndrome
40
studies recruiting now
as of 7 Sept 2026
888
studies registered in total
as of 7 Sept 2026
39
countries with a recruiting site
as of 7 Sept 2026
24 Aug 2026
most recent study posted
among recruiting studies
Recruiting trials
RecruitingNot applicableNCT06849570
Assessment of the PEEP Responsiveness to Titrate End-expiratory Pressure and of the Need for Muscle Relaxation During Prone Positioning in Moderate-to-severe Acute Respiratory Distress Syndrome: A Master Protocol
RecruitingPhase 3NCT05624450
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
RecruitingNCT07781501
Long-Term Study of COVID-19 Infection and Long COVID
RecruitingPhase 3NCT03368092
Inhaled Dornase Alpha to Reduce Respiratory Failure After Severe Trauma
Showing the 5 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
See all 40 recruiting studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
ArgentinaAustraliaBelgiumBrazilBulgariaCanadaChinaColombiaCzechiaDenmarkEgyptFranceGermanyGreeceHong KongHungaryIndiaIsraelItalyJapanMalaysiaMexicoPeruPhilippinesPolandPuerto RicoRomaniaSaudi ArabiaSlovakiaSouth AfricaSouth KoreaSpainSwedenTaiwanThailandTurkey (Türkiye)United KingdomUnited StatesVietnam
Keep watching
Get an email when a new Severe acute respiratory syndrome study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Severe acute respiratory syndrome
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations.
Treatments being studied
54 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.
Phase 3Matrix-M1 Adjuvant
Phase 3Zorecimeran
Phase 3Sabizabulin
Phase 3Ensitrelvir
Phase 3Elasomeran (Spikevax (previously covid-19 vaccine moderna))
Phase 3Tozinameran (Comirnaty)
Phase 3Nvx-Cov2373
Phase 3Hydroxychloroquine
+ 46 more in development
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).